Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease

BACKGROUND: Fibroblast growth factor23 (FGF23) is elevated in CKD and has been associated with outcomes such as death, cardiovascular (CV) events and progression to Renal Replacement therapy (RRT). The majority of studies have been unable to account for change in FGF23 over time and those which have...

Descripción completa

Detalles Bibliográficos
Autores principales: Alderson, Helen V., Chinnadurai, Rajkumar, Ibrahim, Sara T., Asar, Ozgur, Ritchie, James P., Middleton, Rachel, Larsson, Anders, Diggle, Peter J., Larsson, Tobias E., Kalra, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487581/
https://www.ncbi.nlm.nih.gov/pubmed/34600515
http://dx.doi.org/10.1186/s12882-021-02528-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487581/
https://www.ncbi.nlm.nih.gov/pubmed/34600515
http://dx.doi.org/10.1186/s12882-021-02528-2

Ejemplares similares